Cabaletta Bio (CABA) Interest & Investment Income (2018 - 2026)
Cabaletta Bio (CABA) recorded Interest & Investment Income of $1.6 million in Q2 2026, up 13.8% from $1.41 million a year earlier.
Powered by 
Analysis
Cabaletta Bio (CABA) Interest & Investment Income (2018 - 2026) Analysis & Trends
On a TTM basis, Cabaletta Bio's Interest & Investment Income came in at $6.15 million as of Jun 30, 2026, down 15.3% year-over-year; for FY2025, it came in at $6.03 million, down 39.8% from FY2024.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 64.9% (FY2020 to FY2025).
- Across earlier years, Interest & Investment Income came in at $10.03 million in FY2024 (+43.5%), $6.99 million in FY2023 (+500.1%), $1.16 million in FY2022 and $24,000 in FY2021 (-95.1%).
- Quarterly Interest & Investment Income has ranged from $3,000 in Q3 2021 to $2.98 million in Q1 2024 over the past five years.
- On a year-over-year basis, Interest & Investment Income rose in two of the last seven quarters, with an average decline of 20.8%.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 835.3% in Q2 2023, against a decline of 87.0% in Q3 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Cabaletta Bio | 339.09 Mn | 339.09 Mn | - | 1.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | 2.42 Mn |
| Jun 30, 2024 | 2.68 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Dec 31, 2023 | 2.26 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 610,000.00 |
| Sep 30, 2022 | 351,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 6,000.00 |
API Access
Cabaletta Bio Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CABA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CABA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CABA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();